Consultant Endocrinologist, Diabetologist & Obesity Specialist · FRCP, MRCPI

Endocrinology,
Diabetes &
Obesity Medicine

Specialist hormonal, metabolic & weight management
by Dr Syed Kashif Hussain Kazmi FRCP

Expert management of thyroid, pituitary and adrenal disorders, complex type 1 and type 2 diabetes, insulin pump therapy, CGM, GLP-1 receptor agonists (Ozempic, Mounjaro, Wegovy), PCOS, male hypogonadism, and all major endocrine conditions.

Book Endocrinology Appointment GP Referral
3,500+
GLP-1 Patients
20+
Years Experience
FRCP
RCP Glasgow Fellow
Our Endocrinology Service

Expert Hormonal & Metabolic Care

Our endocrinology service covers three deeply related specialties under a single consultant: general endocrinology, diabetes management, and obesity medicine. This integrated approach allows comprehensive metabolic assessment and coordinated treatment — avoiding fragmented care across multiple providers.

Every patient is seen personally by Dr Syed Kashif Hussain Kazmi — a Fellow of the Royal College of Physicians with training at Addenbrooke's Hospital, Cambridge, and on the Specialist Register in both Ireland and the UK.

3,500+
GLP-1 Patients
20+
Years Experience
FRCP
RCP Glasgow Fellow

"Endocrinology, diabetes and obesity are three faces of the same metabolic story — we treat all three together."

Most endocrine conditions exist on a metabolic continuum. Insulin resistance drives not only type 2 diabetes, but obesity, PCOS, dyslipidaemia, and cardiovascular risk. Thyroid disease affects weight, cardiac rhythm, and bone density. Treating each in isolation misses the wider picture.

Our service provides a genuinely integrated metabolic assessment — considering the hormonal, glycaemic, and weight-related dimensions of every patient's health — and coordinates with Dr Kalyar's cardiology service when cardiometabolic risk requires a combined approach.

Three Specialties, One Consultant

Our Clinical Services

Click each specialty to explore the conditions treated and services available.

🦋

Thyroid Disorders

Comprehensive thyroid assessment from initial diagnosis through to long-term management, including specialist thyroid imaging interpretation.

  • Hypothyroidism — diagnosis, levothyroxine optimisation
  • Hyperthyroidism — Graves' disease, toxic nodule
  • Thyroid nodule and goitre assessment
  • Thyroiditis — Hashimoto's, postpartum, De Quervain's
  • Thyroid cancer follow-up and surveillance
  • Subclinical thyroid disease and borderline results
🧠

Pituitary Disorders

Assessment of pituitary function, hormone deficiencies, and pituitary lesions, with coordination of specialist neurological and surgical input where required.

  • Hypopituitarism — growth hormone, ACTH, TSH, gonadotrophin deficiency
  • Prolactinaemia and prolactinoma management
  • Cushing's disease screening and monitoring
  • Acromegaly assessment and follow-up
  • Diabetes insipidus evaluation
  • Post-pituitary surgery endocrine management
🔬

Adrenal Disorders

Evaluation and management of adrenal gland pathology, including incidentally discovered adrenal masses and functional adrenal syndromes.

  • Adrenal incidentaloma assessment and surveillance
  • Primary adrenal insufficiency (Addison's disease)
  • Cushing's syndrome — diagnosis and management
  • Primary hyperaldosteronism (Conn's syndrome)
  • Phaeochromocytoma screening
  • Secondary adrenal insufficiency — steroid withdrawal
🔩

Calcium & Bone Disorders

Specialist management of calcium and bone metabolism disorders, vitamin D deficiency, and related conditions affecting skeletal health.

  • Primary and secondary hyperparathyroidism
  • Hypercalcaemia — investigation and management
  • Hypocalcaemia and hypoparathyroidism
  • Vitamin D deficiency — assessment and replacement
  • Metabolic bone disease including osteoporosis workup
  • Paget's disease and bone turnover assessment
🔄

Male Hypogonadism

Expert evaluation and management of testosterone deficiency and male reproductive endocrine disorders.

  • Testosterone deficiency — diagnosis and testosterone replacement
  • Primary and secondary hypogonadism differentiation
  • Testosterone therapy monitoring
  • Fertility considerations in hypogonadism
  • Late-onset hypogonadism assessment
🌸

PMOS / PCOS & Female Hormones

Assessment of polycystic ovary syndrome and related metabolic complications, alongside other female endocrine presentations.

  • PMOS / PCOS — diagnosis, metabolic and hormonal management
  • Hyperandrogenism and hirsutism evaluation
  • Menstrual irregularity with endocrine cause
  • Insulin resistance in PCOS
  • Metabolic risk in PCOS — cardiovascular and diabetes screening
🩸

Type 1 Diabetes

Expert management of type 1 diabetes including advanced insulin technologies, CGM optimisation, and management of hypoglycaemia unawareness.

  • Complex type 1 diabetes — multi-dose insulin regimen optimisation
  • Hypoglycaemia unawareness assessment and management
  • Continuous Glucose Monitor (CGM) interpretation and optimisation
  • Flash glucose monitoring (FreeStyle Libre) review
  • Insulin pump (CSII) therapy assessment and initiation
  • Hybrid closed-loop system review and counselling
💊

Type 2 Diabetes

Comprehensive management of type 2 diabetes with a focus on cardiovascular risk reduction, renal protection, and modern evidence-based pharmacotherapy.

  • Complex or poorly-controlled type 2 diabetes
  • Insulin initiation and intensification
  • SGLT2 inhibitor therapy — renal and cardiovascular benefit optimisation
  • GLP-1 RA therapy in type 2 diabetes
  • Hypoglycaemia management and regimen simplification
  • Cardiometabolic risk factor optimisation — lipids, blood pressure, weight
🤰

Gestational & Other Diabetes

Specialist assessment of atypical, gestational and rare forms of diabetes requiring expert endocrinological input.

  • Post-gestational diabetes follow-up and prevention
  • MODY (Maturity-Onset Diabetes of the Young) assessment
  • Steroid-induced and post-transplant diabetes
  • Latent Autoimmune Diabetes in Adults (LADA)
  • Pancreatic diabetes
📱

Diabetes Technology

Expert assessment and optimisation of the full range of diabetes devices, including CGM systems, insulin pumps, and closed-loop technology.

  • CGM systems — Dexcom, Libre 2/3, Medtronic
  • Time-in-Range (TIR) analysis and targets
  • Insulin pump therapy (CSII) — initiation and review
  • Hybrid closed-loop (HCL) systems — Omnipod 5, MiniMed 780G
  • Smart pen and connected pen technology review
  • Digital diabetes management tools and apps

GLP-1 Receptor Agonist Therapy

Dr Kazmi has prescribed and personally monitored GLP-1 receptor agonist therapy in over 3,500 patients in the past year alone — one of the most extensive clinical GLP-1RA portfolios in Ireland. This depth of experience spans initiation, dose titration, tolerability management, side-effect monitoring, and long-term structured follow-up across Ozempic, Wegovy, Mounjaro and Saxenda. All prescribing is evidence-based and consultant-supervised at every visit.

Medication safety: Prescription medications including GLP-1 receptor agonists, tirzepatide, insulin, SGLT2 inhibitors, testosterone therapy and thyroid treatments require full medical assessment. Treatment is subject to eligibility, contraindication review, medication availability and shared decision-making, and may not be suitable for every patient.
💉
Semaglutide (Ozempic / Wegovy)
Weekly GLP-1 RA — type 2 diabetes and obesity indications
💉
Tirzepatide (Mounjaro)
A highly effective GLP-1/GIP dual agonist used for eligible patients with type 2 diabetes and/or obesity, subject to clinical assessment.
💉
Liraglutide (Saxenda / Victoza)
Daily GLP-1 RA — diabetes and obesity management
💊
Orlistat, Naltrexone/Bupropion
Additional pharmacotherapy options as clinically indicated
⚖️

Medical Obesity Management

Comprehensive, medically supervised weight management combining pharmacotherapy with metabolic assessment and structured follow-up.

  • Full metabolic and hormonal obesity assessment
  • GLP-1 RA initiation — Ozempic, Mounjaro, Wegovy, Saxenda
  • Structured dose escalation and tolerability review
  • Weight loss targets, maintenance planning and monitoring
  • Assessment of obesity-related co-morbidities
  • Dietary and lifestyle modification alongside pharmacotherapy
📋

Metabolic Risk Assessment

Comprehensive evaluation of cardiometabolic risk factors in overweight and obese patients, integrated with cardiac risk assessment where needed.

  • Insulin resistance and metabolic syndrome evaluation
  • Pre-diabetes screening and intervention
  • Non-alcoholic fatty liver disease (NAFLD) assessment
  • Obstructive sleep apnoea screening
  • Polycystic ovary syndrome and obesity co-management
  • Combined cardiometabolic risk profiling with Dr Kalyar
🏥

Bariatric Surgery Support

Specialist endocrine input for patients considering or recovering from bariatric surgery.

  • Pre-bariatric endocrine and metabolic evaluation
  • Post-operative nutritional and hormonal monitoring
  • Dumping syndrome and post-bariatric hypoglycaemia
  • Diabetes remission monitoring post-surgery
  • Micronutrient deficiency assessment and replacement
Conditions Treated

Common Endocrine Diagnoses

A broad range of hormonal, metabolic and endocrine conditions seen at our clinic.

🦋

Hypothyroidism

Diagnosis, levothyroxine optimisation, Hashimoto's management, subclinical disease, and persistent symptoms despite standard levothyroxine therapy — specialist review and evidence-based discussion of treatment options where clinically appropriate.

⚡

Hyperthyroidism

Graves' disease, toxic multinodular goitre, anti-thyroid drug management and radioiodine counselling.

🩸

Type 1 Diabetes

Complex management, CGM, insulin pump therapy, closed-loop systems, hypoglycaemia unawareness.

💊

Type 2 Diabetes

Insulin initiation, SGLT2i, GLP-1 RA, cardiometabolic risk optimisation and complex glycaemic management.

⚖️

Obesity

Medical weight management with GLP-1 therapy (Ozempic, Mounjaro, Wegovy), metabolic assessment and structured follow-up.

🌸

PMOS / PCOS

Hormonal and metabolic management, insulin resistance, hirsutism, fertility impact and long-term risk reduction. PMOS / PCOS metabolic risk assessment.

🔄

Male Hypogonadism

Testosterone deficiency diagnosis, replacement therapy, monitoring and fertility considerations.

🔬

Adrenal Disease

Addison's disease, adrenal incidentaloma, Cushing's syndrome, Conn's syndrome and adrenal insufficiency.

🔩

Hyperparathyroidism

Primary, secondary and tertiary hyperparathyroidism, hypercalcaemia workup and osteoporosis assessment.

Investigations Arranged

Diagnostics & Testing

A comprehensive range of endocrine and metabolic investigations, arranged promptly and reviewed personally at each follow-up consultation.

Results are reviewed in full context — not just flagged as 'abnormal' — with a clear management plan discussed with the patient and communicated to their GP.

  • 01
    HbA1c & Full Glucose Profiling

    Glycated haemoglobin, fasting glucose, OGTT, and CGM time-in-range analysis for comprehensive diabetes assessment.

  • 02
    Full Thyroid Function Panel

    TSH, free T4, free T3, anti-TPO, anti-thyroglobulin, and thyroid-stimulating immunoglobulins as clinically indicated.

  • 03
    Adrenal Function Testing

    Cortisol, ACTH, 24-hour urinary cortisol, short synacthen test, and aldosterone/renin ratio.

  • 04
    Pituitary Hormone Panel

    IGF-1, prolactin, FSH, LH, testosterone, SHBG, GH stimulation testing as indicated.

  • 05
    Calcium, PTH & Vitamin D

    Adjusted calcium, ionised calcium, PTH, 25-OH vitamin D, phosphate, and 24-hour urinary calcium.

  • 06
    CGM Reports & Download Analysis

    Ambulatory glucose profile (AGP) analysis, time-in-range assessment, and insulin dose optimisation.

  • 07
    Metabolic & Lipid Panel

    Fasting lipids, LDL/HDL, triglycerides, hsCRP, insulin level, full renal and hepatic function.

  • 08
    Imaging Referrals

    Thyroid ultrasound, adrenal CT/MRI, pituitary MRI, DEXA scan — arranged promptly at partnered imaging centres.

Dr Syed Kashif Hussain Kazmi, Consultant Endocrinologist at Naas Cardiology and Endocrinology Clinic
Endocrinology · Diabetes · Obesity Medicine

Dr Syed Kashif Hussain Kazmi

MRCPI (Ireland)  ·  MRCP (UK)  ·  FRCP (Glasgow)  ·  CCT Diabetes, Endocrinology & Internal Medicine (UK)  ·  IMC: 213626  ·  GMC: 6117450

GLP-1 / Ozempic Mounjaro Type 1 Diabetes Insulin Pump CGM Thyroid Adrenal PMOS / PCOS Male Hypogonadism Pituitary
Endocrinology Lead

Your Endocrinologist

Dr Syed Kashif Hussain Kazmi is a Consultant Endocrinologist, Diabetologist, and Obesity Specialist with over 20 years of clinical experience across Ireland, the UK, and internationally. He completed his higher specialist training through the Cambridge/East of England Deanery, with significant experience at Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust — one of the UK's premier academic endocrine centres — and holds a CCT in Diabetes, Endocrinology and Internal Medicine.

He is a Fellow of the Royal College of Physicians (Glasgow), holds MRCP from both the Royal College of Physicians of Ireland and the Royal College of Physicians London (Endocrinology & Diabetes), and is on the Specialist Register in Ireland (IMC: 213626) and the UK (GMC: 6117450). He organised the Adrenal and Pituitary MDTs for the East of England region at Cambridge University Hospitals.

Dr Kazmi has authored multiple peer-reviewed publications in European and British endocrinology journals and has presented at the Society for Endocrinology and the European Congress of Endocrinology. He is a member of the Association of British Clinical Diabetologists (ABCD), Society for Endocrinology UK, and Diabetes UK. He has expertise in Tier 3 medical obesity management including GLP-1 therapy, advanced insulin pump and CGM optimisation, and complex pituitary, adrenal and thyroid disorders.

  • FRCP (Glasgow): Fellow of the Royal College of Physicians, Glasgow (2021)
  • MRCP (UK): Royal College of Physicians London — Endocrinology & Diabetes (2018)
  • MRCPI: Royal College of Physicians of Ireland — General Medicine (2009)
  • CCT: Certificate of Completion of Training — Diabetes, Endocrinology & Internal Medicine (UK, 2019)
  • SCE: Specialty Certificate Examination in Endocrinology and Diabetes
  • Training: Cambridge/East of England Deanery including Addenbrooke's Hospital, Cambridge University Hospitals; Organiser of Adrenal & Pituitary MDTs, East of England
  • Research: Peer-reviewed publications in European & British endocrinology journals; presenter at Society for Endocrinology & European Congress of Endocrinology
  • Memberships: ABCD (Association of British Clinical Diabetologists)  ·  Society for Endocrinology UK  ·  Diabetes UK
  • GLP-1RA Experience: Over 3,500 patients prescribed and personally monitored on GLP-1 receptor agonist therapy in the past year — one of the most extensive clinical GLP-1RA portfolios in Ireland
  • Registration: IMC: 213626  ·  GMC: 6117450 — Specialist Register, Ireland & UK
Preparing for Your Appointment

What to Bring

Book or Refer

Ready to Refer or Book?

We welcome self-referrals and GP referrals for any patient who may benefit from specialist endocrinology, diabetes, or obesity medicine input. Appointments offered promptly.

Our specialist outpatient services are primarily for adult patients aged 18 years and over.

Book Appointment View Cardiology Services →
✉️
Email (Healthmail)

Syed.Kazmi@healthmail.ie

For referrals, clinical queries & correspondence

📍
Clinic Address

Suite 5, Vista Primary Care Clinic
Ballymore Road, Naas, Co. Kildare
W91 E6H2

🕐
Availability

Sunday, by appointment
Prompt scheduling for clinically appropriate referrals. Emergency symptoms should be directed to emergency services.

Send Endocrinology Referral →
Common Questions

Frequently Asked Questions

Do I need a GP referral?
A GP referral letter is recommended and assists with clinical triage and prioritisation. Self-referrals may be accepted at the clinic's discretion. Please contact us to discuss your situation.
Do you manage thyroid disease?
Yes. We manage all common thyroid conditions including hypothyroidism, hyperthyroidism, Graves' disease, thyroid nodules and thyroiditis. Specialist review of persistent symptoms despite standard treatment is also available.
Do you prescribe GLP-1 medications?
GLP-1 receptor agonist medications may be considered for eligible patients following full medical assessment. Prescribing is subject to clinical eligibility, contraindication review, medication availability and shared decision-making.
Can you review complex diabetes?
Yes. We provide specialist management of type 1, type 2 and complex diabetes including review of CGM data, insulin optimisation, technology-supported diabetes management and cardiovascular risk reduction.
Do you review PMOS / PCOS?
Yes. We offer specialist assessment and management of PMOS / PCOS including metabolic risk assessment, hormonal evaluation and evidence-based management of insulin resistance and related conditions.
Do you manage testosterone deficiency?
Yes. We assess and manage male hypogonadism and testosterone deficiency following appropriate investigation and clinical assessment. Treatment is subject to eligibility and shared decision-making.
Can you review CGM, Libre, Dexcom or insulin pump reports?
Yes. We are experienced in reviewing continuous glucose monitoring (CGM) data including FreeStyle Libre, Dexcom and insulin pump reports. Please bring printed or digital reports to your appointment.

Our specialist outpatient services are primarily for adult patients aged 18 years and over.

From the Clinical Blog

Endocrinology

GLP-1 Treatment Guide: Semaglutide & Tirzepatide

Diabetes

Understanding Your HbA1c: What the Number Really Means

Endocrinology

PCOS Renamed PMOS — What This Means for Patients